Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brooks Laboratories is an Indian pharmaceutical company specializing in the manufacturing and marketing of high-quality pharmaceutical formulations. The company focuses on a wide range of therapeutic segments, including antibiotics (specifically Beta-lactams and Carbapenems), cardiovascular drugs, and analgesics. Brooks operates state-of-the-art manufacturing facilities that comply with international standards like WHO-GMP, providing contract manufacturing services to leading global and domestic pharmaceutical firms. Their product portfolio includes injectables, tablets, capsules, and dry syrups, with a significant emphasis on the critical care segment. The company has recently expanded its capabilities through a strategic partnership with Steriscience to focus on specialized injectable products for global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brooks Laboratories.